| Primary |
| Hormone Replacement Therapy |
30.2% |
| Drug Use For Unknown Indication |
28.2% |
| Hot Flush |
9.3% |
| Menopausal Symptoms |
8.1% |
| Menopause |
4.8% |
| Anxiety |
2.8% |
| Hypertension |
2.8% |
| Product Used For Unknown Indication |
2.8% |
| Menopausal Symptoms Prophylaxis |
2.0% |
| Depression |
1.6% |
| Multiple Allergies |
1.2% |
| Arthritis |
0.8% |
| Back Pain |
0.8% |
| Contraception |
0.8% |
| Hypothyroidism |
0.8% |
| Insomnia |
0.8% |
| Vulvovaginal Dryness |
0.8% |
| Abdominal Discomfort |
0.4% |
| Acne |
0.4% |
| Atrophic Vulvovaginitis |
0.4% |
|
| Vaginal Haemorrhage |
16.9% |
| Metrorrhagia |
13.2% |
| Alopecia |
6.6% |
| Headache |
6.6% |
| Vertigo |
6.6% |
| Weight Increased |
6.6% |
| Pain In Extremity |
4.4% |
| Postmenopausal Haemorrhage |
4.4% |
| Endometrial Cancer Stage I |
3.7% |
| Visual Disturbance |
3.7% |
| Breast Tenderness |
2.9% |
| Muscle Spasms |
2.9% |
| Nausea |
2.9% |
| No Adverse Event |
2.9% |
| Speech Disorder |
2.9% |
| Vision Blurred |
2.9% |
| Vomiting |
2.9% |
| Drug Ineffective |
2.2% |
| Hepatic Steatosis |
2.2% |
| Hot Flush |
2.2% |
|
| Secondary |
| Hormone Replacement Therapy |
43.8% |
| Hot Flush |
10.4% |
| Anxiety |
4.2% |
| Drug Use For Unknown Indication |
4.2% |
| Insomnia |
4.2% |
| Loss Of Libido |
4.2% |
| Night Sweats |
4.2% |
| Vulvovaginal Dryness |
4.2% |
| Acne |
2.1% |
| Atrophic Vulvovaginitis |
2.1% |
| Chills |
2.1% |
| Hypertension |
2.1% |
| Hypothyroidism |
2.1% |
| Menopausal Symptoms |
2.1% |
| Menopausal Symptoms Prophylaxis |
2.1% |
| Postmenopause |
2.1% |
| Rhinitis |
2.1% |
| Skin Disorder |
2.1% |
|
| Vertigo |
27.6% |
| Postmenopausal Haemorrhage |
10.3% |
| Retinal Vein Thrombosis |
10.3% |
| Night Sweats |
6.9% |
| No Adverse Event |
6.9% |
| Abdominal Pain |
3.4% |
| Acne |
3.4% |
| Anxiety |
3.4% |
| Blood Corticotrophin Increased |
3.4% |
| Dizziness |
3.4% |
| Hot Flush |
3.4% |
| Nausea |
3.4% |
| Osteochondrosis |
3.4% |
| Secretion Discharge |
3.4% |
| Weight Decreased |
3.4% |
| Weight Increased |
3.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
35.8% |
| Hormone Replacement Therapy |
7.9% |
| Rheumatoid Arthritis |
7.9% |
| Prophylaxis |
7.3% |
| Depression |
4.0% |
| Menopause |
4.0% |
| Non-small Cell Lung Cancer |
4.0% |
| Hormone Therapy |
3.3% |
| Hypertension |
3.3% |
| Fibromyalgia |
2.6% |
| Osteoporosis |
2.6% |
| Relapsing-remitting Multiple Sclerosis |
2.6% |
| Bipolar Disorder |
2.0% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Hypothyroidism |
2.0% |
| Menopausal Symptoms |
2.0% |
| Pain |
2.0% |
| Tobacco User |
2.0% |
| Abdominal Pain Upper |
1.3% |
| Anaemia |
1.3% |
|
| Lumbar Vertebral Fracture |
12.0% |
| Alanine Aminotransferase Increased |
8.0% |
| Injection Site Pain |
8.0% |
| Withdrawal Syndrome |
8.0% |
| Anaphylactic Shock |
4.0% |
| Arrhythmia |
4.0% |
| Blood Sodium Decreased |
4.0% |
| Central Nervous System Lesion |
4.0% |
| Delusional Disorder, Unspecified Type |
4.0% |
| Depressed Mood |
4.0% |
| Emotional Disorder |
4.0% |
| Emotional Distress |
4.0% |
| Endometritis |
4.0% |
| Incorrect Route Of Drug Administration |
4.0% |
| Inflammation |
4.0% |
| Injection Site Pruritus |
4.0% |
| Intraductal Proliferative Breast Lesion |
4.0% |
| Major Depression |
4.0% |
| Musculoskeletal Disorder |
4.0% |
| Musculoskeletal Pain |
4.0% |
|
